Back extensor strength and incident GERD in women receiving osteoporosis treatment: a retrospective cohort study
Journal of Bone and Mineral Metabolism · 07.11.2026
DOI: 10.1007/s00774-026-01781-5 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Bone and Mineral Metabolism, online erschienen am 07.11.2026. Verfasst von Hiromichi Abe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Akita University.
Abstract (Originalsprache)
Introduction
We investigated factors associated with incident gastroesophageal reflux disease (GERD) in women receiving osteoporosis treatment. Materials and methods This retrospective cohort study included 82 women with osteoporosis, baseline Frequency Scale for the Symptoms of GERD (FSSG) scores < 8, and an available follow-up assessment at least 4 years later. Incident questionnaire-defined GERD was defined as a final follow-up FSSG score ≥ 8 among participants with baseline scores < 8. Clinical characteristics, radiographic parameters, bone mineral density (BMD), body composition, and muscle strength were compared between groups. Separate age-adjusted logistic regression models assessed follow-up back extensor strength and percentage changes in back extensor strength and lumbar spine BMD expressed as a percentage of the young adult mean (%YAM).
Results
At the final follow-up assessment, 19 participants (23.2%) were classified as GERD-positive. Follow-up back extensor strength was lower in the GERD group (10.6 ± 4.5 vs 14.3 ± 5.7 kg; p = 0.011). Higher follow-up back extensor strength was associated with lower odds of incident GERD (age-adjusted odds ratio, 0.86 per 1-kg increase; 95% confidence interval, 0.76–0.98; p = 0.019). Neither percentage change was significantly associated with incident GERD. BMD increased during follow-up, and radiographic parameters did not differ significantly between groups.
Conclusion
Lower back extensor strength at follow-up was associated with questionnaire-defined GERD in women receiving osteoporosis treatment. Although temporal and causal relationships remain uncertain, prospective studies with strength assessments before symptom onset could clarify this association and inform future trials of back extensor strengthening.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan.
- Department of Orthopedic Surgery, Kakunodate General Hospital, 3 Iwase, Kakunodatemachi, Semboku-shi, Akita, 014-0394, Japan.
- Department of Orthopedic Surgery, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan. oyuichi@med.akita-u.ac.jp.
- Department of Rehabilitation Medicine, Akita University Hospital, 44-2 Hiroomote, Akita, Akita, 010-0041, Japan.
- Department of Physical Therapy, Akita University School of Health Sciences, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan.
Förderung
- Akita University
Zitieren
APA
Abe, H., Ono, Y., Kasukawa, Y., Tsuchie, H., Hongo, M., & Miyakoshi, N. (2026). Back extensor strength and incident GERD in women receiving osteoporosis treatment: a retrospective cohort study. Journal of Bone and Mineral Metabolism. https://doi.org/10.1007/s00774-026-01781-5
Vancouver
Abe H, Ono Y, Kasukawa Y, Tsuchie H, Hongo M, Miyakoshi N. Back extensor strength and incident GERD in women receiving osteoporosis treatment: a retrospective cohort study. Journal of Bone and Mineral Metabolism. 2026. doi:10.1007/s00774-026-01781-5
BibTeX
@article{Abe2026,
author = {Abe, Hiromichi and Ono, Yuichi and Kasukawa, Yuji and Tsuchie, Hiroyuki and Hongo, Michio and Miyakoshi, Naohisa},
title = {Back extensor strength and incident GERD in women receiving osteoporosis treatment: a retrospective cohort study},
journal = {Journal of Bone and Mineral Metabolism},
year = {2026},
doi = {10.1007/s00774-026-01781-5}
}
EUVIMED